ArticleDiagnostic and interventional radiology (Ankara, Turkey)2026
Normal physiological variants and benign conditions in pelvic oncologic fluorodeoxyglucose positron emission tomography/magnetic resonance imaging.
Article in Diagnostic and interventional radiology (Ankara, Turkey), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fluorodeoxyglucose (FDG) positron emission tomography (PET)/magnetic resonance imaging (MRI) is an advanced hybrid imaging modality that holds substantial promise in oncologic imaging. FDG PET, a well-established molecular imaging technique, enables assessment of tumor glucose metabolism and is widely utilized for diagnosing and monitoring a range of malignancies; MRI offers superior soft tissue contrast, facilitating precise anatomical localization of PET findings. This pictorial essay presents a series of physiological FDG uptake variants observed in the uterus, fallopian tubes, ovaries, colon, internal anal sphincter, pelvic musculature, and bone marrow. Additionally, it highlights benign conditions such as uterine tumors, vaginal condyloma acuminatum, and infected Bartholin cysts that may exhibit FDG uptake and potentially mimic malignancy. The essay also illustrates FDG-avid post-treatment changes and various infectious and inflammatory lesions such as osteitis pubis, perianal fistulas, and pelvic abscesses that may complicate oncologic interpretation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.